or
forgot password

    • cancer clinical trials in hinsdale, IL

    • Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Gestational Trophoblastic Tumor
    Everolimus in Treating Patients With Stage IV Melanoma

    Hinsdale, Illinois 60521
    Melanoma (Skin)
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Sarcoma
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Hinsdale Hematology Oncology Associates

    Trial Locations
    Hinsdale Hematology Oncology Associates
    Breast Cancer
    Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

    Hinsdale, Illinois 60521
    Acute Myeloid Leukemia
    Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)

    Hinsdale, Illinois 60521
    Leukemia, Lymphocytic, Chronic, B-Cell
    Trial of Decitabine in Patients With Acute Myeloid Leukemia

    Hinsdale, Illinois 60521
    Acute Myeloid Leukemia
    A Long-term Safety Study of Infliximab (Remicade)

    Hinsdale, Illinois 60521
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies

    Hinsdale, Illinois 60521
    Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma, Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia
    Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

    Hinsdale, Illinois 60521
    B-cell Acute Lymphoblastic Leukemia
    Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

    Hinsdale, Illinois 60521
    Breast Cancer, Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Hinsdale Hematology Oncology Associates Incorporated
    Hinsdale, Illinois 60521
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

    Hinsdale, Illinois 60521
    Blood Loss, Surgical, Postoperative Hemorrhage
    Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Lymphoma
    Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

    Hinsdale, Illinois 60521
    Breast Cancer, Sexual Dysfunction, Sexuality and Reproductive Issues
    Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Carcinoma of Unknown Primary, Pain
    Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer

    Hinsdale, Illinois 60521
    Dermatologic Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Methylphenidate in Treating Patients With Fatigue Caused by Cancer

    Hinsdale, Illinois 60521
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
    Gynecologic Oncology - Hinsdale
    Hinsdale, Illinois 60521
    Ovarian Cancer
    Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Sarcoma
    ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

    Hinsdale, Illinois 60521
    Metastatic Breast Cancer
    Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

    Hinsdale, Illinois 60521
    Hematologic Neoplasms, Bone Marrow Neoplasms, Non-Hodgkin's Lymphoma
    Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

    Hinsdale, Illinois 60521
    Breast Cancer, Dermatologic Complications, Radiation Toxicity, Skin Reactions Secondary to Radiation Therapy
    Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Cervical Cancer
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Hinsdale Hematology Oncology Associates
    Hinsdale, Illinois 60521
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma

    Hinsdale, Illinois 60521
    Lymphoma, B-Cell